Hyperimmune plasma to treat viral or bacterial disease has been used many time in the past but this kind of treatment has several limitations that can be solved by the isolation of antigen-specific inmunoglobulins against SARS-COV-2 from the plasma of convalescent patients that have passed the disease. This product may help to cure o protect subjects from the infection. I am looking for a pharmaceutical company willing to perform a collaborative project in this field.
First write down exactly what your capabilities are, what your proposal is, what the risks are, what the liabilities are, what time and resources are required. Prepare your credentials for scrutiny.
Pharma isn't generally interested in finding new projects to pursue. Talk to government. Pick up the phone and call researchers who do similar research and talk to them.
Most likely, if ANYthing happens, you might get invited to work for another company. Unless you're already running your own established lab, there's almost no incentive to partner with you when they established company could simply own the idea.